Greg Yap
Greg Yap is a partner at Menlo Ventures, where he invests in life science and healthcare companies with a focus on novel therapeutic platforms, digital health, and transformative technologies. He joined Menlo Ventures in 2017 and has led investments in companies including Clear Labs, Delfi Diagnostics, Pliant Therapeutics, and Xaira. Prior to venture capital, he held senior executive roles at Roche Diagnostics, Affymetrix, and McKinsey & Company, and co-founded two startups in therapeutics and digital health.
“It's not a sustainable business because what happens when people stop writing articles about the bad lettuce? People stop spending money on the bad lettuce problem. — Greg Yap, Menlo Ventures”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.